US EditionCoulter Partners places experienced R&D leader and biotech entrepreneur as CEO of Nuage Therapeutics - Hunt Scanlon Media
Summary by Hunt Scanlon Media
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Coulter Partners places experienced R&D leader and biotech entrepreneur as CEO of Nuage Therapeutics - Hunt Scanlon Media
Coulter Partners is proud of the successful placement of Dr. Stuart Hughes as Chief Executive Officer at Nuage Therapeutics S.L. (“Nuage”). Nuage is a biotech company focused on creating transformational precision therapies by targeting established oncogenic transcription factors. The Company has developed a set of tools that enables the reconstitution of intrinsically-disordered proteins (IDPs) in a secondary-structured form that renders them a…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
